Focus

tag
Ebola Virus Disease ( Ebola Hemorrhagic Fever)

In the throes of Ebola, now, measles kills more than 4,000 in the Congo

Paucity of funds, armed conflicts adversely affecting health response: WHO

SHARE

WHO’s Ebola vaccination strategy ineffective in DRC: MSF

The aid agency has also called for an independent, international committee to manage Ebola vaccine stocks and their use 

&…

SHARE

Make pandemic preparedness in Africa affordable: WHO

New regional strategy prepared by UN body on disease surveillance and response says investing in pandemic preparedness is an affordable public …

SHARE

Possible Ebola cure: 2 drugs successful in preventing death

Two of four potential drug candidates found to cure disease, says WHO

SHARE

Why declaring Ebola a public health emergency isn't a silver bullet

More funding can't solve the outbreak of a deadly disease within a conflict zone

SHARE

Now, Ebola case surfaces in Uganda

Five-year-old child who travelled from Democratic Republic of the Congo to Uganda, down with  disease

SHARE

Ebola in Africa's Democratic Republic of Congo now has more than 2,000 infected

The current outbreak of the virus, beginning late July 2018, has claimed 1,346 lives in North Kivu and Ituri provinces until May.

SHARE

Radical ideas are needed to break the DRC’s Ebola outbreak. Here are some

The deaths in this outbreak are 10% of the total deaths recorded in West Africa in 2014, which took more than 11,000 lives

SHARE

Ebola survivors can lose their eyesight. What we're doing to prevent it

Translating lessons learnt during the outbreak in West Africa into improved vision health is an ongoing necessity in Congo

SHARE

Why Ebola vaccine on trial in the DRC is raising hopes

The viral disease burden in Africa is largely underestimated and the rVSV-ZEBOV is a much-needed vaccine in the fight against Ebola

SHARE

Ebola outbreak in Democratic Republic of Congo second biggest

Death toll crosses 350; American doctor quarantined; aid work suffers due to violence

SHARE

Twin studies pave way for Ebola, Zika and dengue treatment

Researchers use protein-to-protein interaction between viruses and human cells to narrow down on potential treatment targets

SHARE